BRIEF-MediciNova says exploratory interim clinical outcomes data from clinical trial of MN-166 in ALS
April 25, 2017 at 23:24 PM EDT
* Says it announced exploratory interim clinical outcomes data from clinical trial of MN-166 (ibudilast) in ALS presented at the American Academy of Neurology (AAN) 69th Annual Meeting in Boston
